Wang R - Search Results

1

The PDGF-D/miR-106a/Twist1 pathway orchestrates epithelial-mesenchymal transition in gemcitabine resistance hepatoma cells.

Wang R, Li Y, Hou Y, Yang Q, Chen S, Wang X, Wang Z, Yang Y, Chen C, Wang Z, Wu Q. Wang R, et al. Among authors: wang x, wang z. Oncotarget. 2015 Mar 30;6(9):7000-10. doi: 10.18632/oncotarget.3193. Oncotarget. 2015. PMID: 25760076 Free PMC article.

2

Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway.

Wu Q, Wang R, Yang Q, Hou X, Chen S, Hou Y, Chen C, Yang Y, Miele L, Sarkar FH, Chen Y, Wang Z. Wu Q, et al. Among authors: wang z, wang r. Oncotarget. 2013 Nov;4(11):1999-2009. doi: 10.18632/oncotarget.1471. Oncotarget. 2013. PMID: 24158561 Free PMC article.

3

Gemcitabine resistance is associated with epithelial-mesenchymal transition and induction of HIF-1α in pancreatic cancer cells.

Wang R, Cheng L, Xia J, Wang Z, Wu Q, Wang Z. Wang R, et al. Among authors: wang z. Curr Cancer Drug Targets. 2014;14(4):407-17. doi: 10.2174/1568009614666140226114015. Curr Cancer Drug Targets. 2014. PMID: 24575976

4

MiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells.

Liu Y, Li Y, Wang R, Qin S, Liu J, Su F, Yang Y, Zhao F, Wang Z, Wu Q. Liu Y, et al. Among authors: wang z, wang r. J Exp Clin Cancer Res. 2016 Jan 27;35:19. doi: 10.1186/s13046-016-0296-0. J Exp Clin Cancer Res. 2016. PMID: 26817584 Free PMC article.

5

Nutlin-3 reverses the epithelial-mesenchymal transition in gemcitabine-resistant hepatocellular carcinoma cells.

Wu Q, Wang X, Liu J, Zheng J, Liu Y, Li Y, Su F, Ou W, Wang R. Wu Q, et al. Among authors: wang x, wang r. Oncol Rep. 2016 Sep;36(3):1325-32. doi: 10.3892/or.2016.4920. Epub 2016 Jul 8. Oncol Rep. 2016. PMID: 27430152

6

Over-expression of Thrombospondin 4 correlates with loss of miR-142 and contributes to migration and vascular invasion of advanced hepatocellular carcinoma.

Su F, Zhao J, Qin S, Wang R, Li Y, Wang Q, Tan Y, Jin H, Zhu F, Ou Y, Cheng Z, Su W, Zhao F, Yang Y, Zhou Z, Zheng J, Li Y, Li Z, Wu Q. Su F, et al. Among authors: wang r, wang q. Oncotarget. 2017 Apr 4;8(14):23277-23288. doi: 10.18632/oncotarget.15054. Oncotarget. 2017. PMID: 28177895 Free PMC article.

7

Functional role of miR-34 family in human cancer.

Wang R, Ma J, Wu Q, Xia J, Miele L, Sarkar FH, Wang Z. Wang R, et al. Among authors: wang z. Curr Drug Targets. 2013 Sep;14(10):1185-91. doi: 10.2174/13894501113149990191. Curr Drug Targets. 2013. PMID: 23834144 Review.

8

[Effect of Oxaliplatin on cell cycle of hepatocellular carcinoma cell line HepG2].

Gao J, Wang R, Yang Q, Chen C, Wu Q. Gao J, et al. Among authors: wang r. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2013 Jul;42(4):437-42. doi: 10.3785/j.issn.1008-9292.2013.04.011. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2013. PMID: 24022933 Chinese.

9

[Expression of gap junction protein connexin 26 in human hepatocellular carcinoma and its significance].

Yang Y, Li YM, Zhang N, Li WY, Ou YR, Wang R, Zhao FY, Wu Q. Yang Y, et al. Among authors: wang r. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2015 Sep;44(5):517-24. doi: 10.3785/j.issn.1008-9292.2015.09.08. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2015. PMID: 26713526 Free PMC article. Chinese.

10

Role of IL-33 expression in oncogenesis and development of human hepatocellular carcinoma.

Yang Y, Wang JB, Li YM, Zhao YU, Wang R, Wu Q, Zheng RS, Ou YR. Yang Y, et al. Among authors: wang jb, wang r. Oncol Lett. 2016 Jul;12(1):429-436. doi: 10.3892/ol.2016.4622. Epub 2016 May 25. Oncol Lett. 2016. PMID: 27347162 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39,036 results

Search Page